UA99604C2 - Соль нападисилата как антагонист мускаринового рецептора м3 - Google Patents

Соль нападисилата как антагонист мускаринового рецептора м3

Info

Publication number
UA99604C2
UA99604C2 UAA200907421A UAA200907421A UA99604C2 UA 99604 C2 UA99604 C2 UA 99604C2 UA A200907421 A UAA200907421 A UA A200907421A UA A200907421 A UAA200907421 A UA A200907421A UA 99604 C2 UA99604 C2 UA 99604C2
Authority
UA
Ukraine
Prior art keywords
muscarinic
antagonist
napadisylate salt
napadisylate
methyl
Prior art date
Application number
UAA200907421A
Other languages
English (en)
Ukrainian (uk)
Inventor
Барбара Джузеппина Авитабиле
Дейвид О'Салливан
Ричард Джеймс Булл
Original Assignee
Арджента Дискавери Лимитед
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37898913&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA99604(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Арджента Дискавери Лимитед, Астразенека Аб filed Critical Арджента Дискавери Лимитед
Publication of UA99604C2 publication Critical patent/UA99604C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
UAA200907421A 2007-02-07 2008-02-06 Соль нападисилата как антагонист мускаринового рецептора м3 UA99604C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0702385.6A GB0702385D0 (en) 2007-02-07 2007-02-07 New combination

Publications (1)

Publication Number Publication Date
UA99604C2 true UA99604C2 (ru) 2012-09-10

Family

ID=37898913

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200907421A UA99604C2 (ru) 2007-02-07 2008-02-06 Соль нападисилата как антагонист мускаринового рецептора м3

Country Status (18)

Country Link
US (1) US20110046191A1 (ru)
EP (1) EP2124941A1 (ru)
JP (1) JP5337054B2 (ru)
KR (1) KR20090114389A (ru)
CN (2) CN101636390B (ru)
AR (1) AR065202A1 (ru)
AU (1) AU2008212649B2 (ru)
BR (1) BRPI0806966A2 (ru)
CA (1) CA2675718A1 (ru)
CL (1) CL2008000380A1 (ru)
GB (1) GB0702385D0 (ru)
MX (1) MX2009008363A (ru)
PE (1) PE20081751A1 (ru)
RU (1) RU2460527C2 (ru)
TW (1) TW200901986A (ru)
UA (1) UA99604C2 (ru)
WO (1) WO2008096126A1 (ru)
ZA (1) ZA200905106B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
GB0704000D0 (en) * 2007-03-01 2007-04-11 Astrazeneca Ab Salts 670
EP2300464A1 (en) 2008-05-13 2011-03-30 AstraZeneca AB Quinuclidine derivatives as muscarinic m3 receptor antagonists
WO2009154562A1 (en) * 2008-06-20 2009-12-23 Astrazeneca Ab Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity
GB0814728D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
GB0823140D0 (en) * 2008-12-18 2009-01-28 Astrazeneca Ab New combination
PL3061821T3 (pl) 2009-07-22 2020-01-31 PureTech Health LLC Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
BR112021005802B1 (pt) 2018-09-28 2022-02-15 Karuna Therapeutics, Inc Composição farmacêutica oral
CN109896934A (zh) * 2019-03-08 2019-06-18 山东省药学科学院 一种高纯度2-苄氧基溴乙烷的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
FR2675142B1 (fr) * 1991-04-10 1993-06-25 Roussel Uclaf Nouveaux derives de l'acide alpha-methylene 4-[(phenoxy) methyl] 5-thiazolacetique, leur procede de preparation et les intermediaires de ce procede et leur application a titre de fongicides.
GB9603755D0 (en) * 1996-02-22 1996-04-24 Pfizer Ltd Therapeutic agents
US6057340A (en) * 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
US6242448B1 (en) * 1998-12-17 2001-06-05 American Home Products Corporation Trisubstituted-oxazole derivatives as serotonin ligands
SE9902935D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
US20020052312A1 (en) * 2000-05-30 2002-05-02 Reiss Theodore F. Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
US20020179087A1 (en) * 2001-02-01 2002-12-05 Karl-Heinz Bozung Pharmaceutical compositions containing an oxitropium salt and a betamimetic
US20020189610A1 (en) * 2001-02-01 2002-12-19 Karl-Heinz Bozung Pharmaceutical compositions containing an ipratropium salt and a betamimetic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
NZ538493A (en) * 2002-08-29 2007-10-26 Cipla Ltd Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US20050025718A1 (en) * 2003-07-31 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a betamimetic
US7745621B2 (en) * 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200738658A (en) * 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
WO2008017827A2 (en) * 2006-08-08 2008-02-14 Argenta Discovery Limited Azole and thiazole derivatives and their uses
WO2008096093A1 (en) * 2007-02-06 2008-08-14 Argenta Discovery Ltd. Oxazole and thiazole derivatives and their uses

Also Published As

Publication number Publication date
CN101636390A (zh) 2010-01-27
MX2009008363A (es) 2009-08-20
WO2008096126A1 (en) 2008-08-14
CN101678005B (zh) 2012-10-31
CL2008000380A1 (es) 2008-08-18
JP2010518059A (ja) 2010-05-27
CA2675718A1 (en) 2008-07-14
EP2124941A1 (en) 2009-12-02
AU2008212649B2 (en) 2011-05-19
TW200901986A (en) 2009-01-16
RU2009133261A (ru) 2011-03-20
GB0702385D0 (en) 2007-03-21
KR20090114389A (ko) 2009-11-03
JP5337054B2 (ja) 2013-11-06
CN101636390B (zh) 2013-06-12
AU2008212649A1 (en) 2008-08-14
BRPI0806966A2 (pt) 2014-04-08
PE20081751A1 (es) 2008-12-27
CN101678005A (zh) 2010-03-24
AR065202A1 (es) 2009-05-20
RU2460527C2 (ru) 2012-09-10
US20110046191A1 (en) 2011-02-24
ZA200905106B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
UA99604C2 (ru) Соль нападисилата как антагонист мускаринового рецептора м3
WO2008096149A3 (en) Napadisylate salt of a muscarinic m3 antagonist
EP1909772A4 (en) TRANSDERMAL DRUG FORMULATION
EP2010125A4 (en) DOS COUNTER
IL193894A (en) Pharmaceuticals containing loliconazole for external use
IL174352A0 (en) Medical devices for use with carpules
SI2063868T1 (sl) Farmacevtski sestavki, ki vsebujejo kalcijev rosuvastatin
PL2058020T3 (pl) Urządzenie do podawania leków
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
GB0515584D0 (en) Medicament dispenser
IL191940A0 (en) Medicament dispenser
ZA200807484B (en) Medicament containing fluoroquinolones
IL185889A0 (en) Dispenser for delivering medicament
EP2010162A4 (en) COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
GB0600070D0 (en) Dose counter
EP1862183A4 (en) PHARMACEUTICAL COMPOSITION WITH HEAVY WATER-SOLUBLE MEDICAMENT
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-SKIN COMPOSER
MX2012011382A (es) Nuevo polimero.
JO2730B1 (en) Medications for the treatment of endometriosis
IL195034A0 (en) Liquid pharmaceutical formulation
IL199865A0 (en) Methods of determining drug dose delivery
PL1996157T3 (pl) Oftalmiczna kompozycja farmaceutyczna zawierająca amfifilowe kopolimery poliaspartamidu
WO2008146104A3 (en) Stable liquid composition of chondroitinsulfate and glucosamine
EP2309856A4 (en) PHARMACEUTICAL COMPOUNDS AS CYTOTOXICA AND ITS APPLICATION